You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 101 No. 6, June 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Hematoporphyrin Phototherapy for Experimental Intraocular Malignant Melanoma

Luke H. S. Liu, MD; Chuo Ni, MD

Arch Ophthalmol. 1983;101(6):901-903.


Abstract



• Administration of a hematoporphyrin derivative (HpD) followed by photoradiation with red light completely or partially destroyed Greene hamster melanoma developed in the anterior chamber of rabbit eyes. Tumor-bearing eyes were divided into two groups. Twenty-two eyes received an HpD injection followed by exposure to red light from a slide projector with a 500-W quartz halogen lamp and a red filter (intensity to the tumor was about 4.0 mW/sq cm). In the control group (six eyes), eyes were exposed either to red light only or to HpD injection only. Local complications after therapy included edema and congestion of the conjunctiva, clouding of the cornea, and hemorrhage on the iris surface. The HpD itself has no cytotoxic effect, is preferentially retained in tumor cells, and causes a destructive photodynamic effect as a result of the production of cytotoxic singlet oxygen in the tumor. Accordingly, it may be a safe and potentially therapeutic procedure in the treatment of uveal melanoma. n.amon



Author Affiliations



From the Eye Research Institute of Retina Foundation, Boston.


Footnotes



Accepted for publication July 19, 1983.

Reprint requests to Eye Research Institute, 20 Staniford St, Boston, MA 02114 (Dr Liu).

This study was supported by research grant EY-03609 from the National Eye Institute.

Daniel M. Albert, MD, reviewed the manuscript. The hematoporphyrin derivative was obtained from Thomas J. Dougherty, MD, Roswell Park Memorial Institute, Buffalo.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Photodynamic Therapy for Experimental Intraocular Melanoma Using Chloroaluminum Sulfonated Phthalocyanine
Panagopoulos et al.
Arch Ophthalmol 1989;107:886-890.
ABSTRACT  

Fluorouracil Therapy of Intraocular Greene Melanoma in the Rabbit
Olsen et al.
Arch Ophthalmol 1988;106:812-815.
ABSTRACT  

Hematoporphyrin Photoradiation Therapy for Intraocular and Orbital Malignant Melanoma
Tse et al.
Arch Ophthalmol 1984;102:833-838.
ABSTRACT  

Neovascular Glaucoma After Photoradiation Therapy for Uveal Melanoma
Lewis et al.
Arch Ophthalmol 1984;102:839-842.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.